The forecast for Parkinson's Disease mortality among males in the U.S. shows a steady upward trend from 2024 to 2028, increasing from 31.41 thousand male deaths to 38.59 thousand. In 2023, the mortality rate stood significantly lower, indicating a rising challenge. Year-on-year variations show a consistent increase averaging around 5% annually. Over the last five years, the compounded annual growth rate (CAGR) underlines a gradually accelerating concern with a near consistent rise.

Future trends to watch for include:

Continued advancements in medical research and treatment options aimed at reducing mortality rates.
Potential demographic shifts affecting Parkinson’s prevalence in an aging population.
Increased focus on early detection and prevention strategies to counteract rising trends.